[Detection, evaluation, target and clinical significance of dyslipidemia management].
作者信息
Sasaki Jun
机构信息
Graduate School of Clinical Trial Management, International University of Health and Welfare.
出版信息
Nihon Rinsho. 2007 Jul 28;65 Suppl 7:429-34.
PMID:17824067
Abstract
摘要
相似文献
1
[Detection, evaluation, target and clinical significance of dyslipidemia management].血脂异常管理的检测、评估、目标及临床意义
Nihon Rinsho. 2007 Jul 28;65 Suppl 7:429-34.
2
[How to apply clinical guidelines in medical practice? The example of dyslipidemia].[如何在医疗实践中应用临床指南？以血脂异常为例]
Rev Med Suisse. 2008 Mar 12;4(148):662-5.
3
[Dyslipidemia].[血脂异常]
Rev Prat. 2011 Jan;61(1):93-102.
4
Update on evidence-based diagnosis and management of mixed dyslipidemias.混合性血脂异常的循证诊断与管理最新进展
P R Health Sci J. 2008 Dec;27(4):390-4.
5
Challenges of existing pediatric dyslipidemia guidelines: call for reappraisal.现有儿童血脂异常指南面临的挑战：呼吁重新评估。
Circulation. 2008 Jan 1;117(1):9-10. doi: 10.1161/CIRCULATIONAHA.107.743104.
6
[Czech atherosclerosis society guidelines for the diagnosis and treatment of dyslipidemia in adults].[捷克动脉粥样硬化学会成人血脂异常诊断与治疗指南]
Cas Lek Cesk. 2007;146(6):II-XV.
7
Treating dyslipidemia: re-evaluating the data using evidence-based medicine.
J Am Osteopath Assoc. 2010 Apr;110(4 Suppl 5):eS6-11.
8
[Genetics of dyslipidemia--yesterday, today, and tomorrow].
Vnitr Lek. 2007 Apr;53(4):371-6.
9
[Czech Atherosclerosis Society Guidelines for the diagnosis and treatment of dyslipidemias in adults].[捷克动脉粥样硬化协会成人血脂异常诊断与治疗指南]
Vnitr Lek. 2007 Feb;53(2):181-7, 189, 191-3 passim.
10
[A study on the capability of dyslipidemia diagnosis and treatment among 42 community hospitals in Beijing].
Zhonghua Liu Xing Bing Xue Za Zhi. 2006 Sep;27(9):757-60.
Zotero 插件